Multiple Sclerosis

The NeurologyLive® MS Disease Spotlight page offers specific updates and coverage on the latest expert conversations and data readouts related to the treatment and management of patients with multiple sclerosis and demyelinating disorders.

Latest News

Carla LoPinto-Khoury, MD, FAES, Associate Professor of Neurology, Lewis Katz School of Medicine, Temple University
Navigating Treatment Decision-Making in Multiple Sclerosis

March 24th 2024

In a paradigm with many options, once multiple sclerosis is confirmed as a patient’s diagnosis, physicians are left with 1 question: What do we choose for long-term treatment?

IJMSC Online First: March 2024
IJMSC Online First: March 2024

March 22nd 2024

Dimitrios Karussis, MD, PhD
Repeated Intrathecal Injection of NeuroGenesis’ Mesenchymal Stem Cell Therapy Reveals Potential Benefit in Progressive MS

March 16th 2024

FDA Issues Complete Response Letter for Long-Acting Form of Glatiramer Acetate for Relapsing Multiple Sclerosis
FDA Issues Complete Response Letter for Long-Acting Form of Glatiramer Acetate for Relapsing Multiple Sclerosis

March 11th 2024

Barry A. Singer, MD
Switching From Anti-CD20 Therapy to Ublituximab Shows Promising Results in Phase 3b ENHANCE Trial

March 7th 2024

<1
...
© 2024 MJH Life Sciences

All rights reserved.